×
Back to Agenda
Session 5: Keynote Address
Session Chair(s)
James Wild, PHD, MS
Pharmacologist, CDER, FDA, United States
Session 5: Keynote Address
Speaker(s)
James D. Thompson, PHD
CMC Therapeutic Area Lead, Moderna Therapeutics , United States
Session Co-Chair
Philip (P.J.) Brooks, PHD
Deputy Director, Division of Rare Diseases Research Innovation, National Center for Advancing Translational Sciences (NCATS), NIH, United States
Keynote
Arthur M. Krieg, MD
CEO and CSO, Checkmate Pharmaceuticals, United States
Speaker
Have an account?